FDA.reportPublic FDA data

Lytgobi 16 MG Daily Dose - 4 MG (28)

RxCUI
2628206
RxNorm name
Lytgobi 16 MG Daily Dose - 4 MG (28)
Display name
Lytgobi 16 MG Daily Dose - 4 MG (28)
Full name
Lytgobi 16 MG Daily Dose - 4 MG (28)
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LYTGOBIFUTIBATINIBTAIHO PHARMACEUTICAL CO., LTD.0b1332a1-0581-4707-9bf6-1eccfa39bef42025-10-27Warnings, Adverse reactionsExact identifier
rxcui: 2628206

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0b1332a1-0581-4707-9bf6-1eccfa39bef4{28 (futibatinib 4 MG Oral Tablet [Lytgobi]) } Pack [Lytgobi 16 MG Daily Dose] [BPCK] · LYTGOBI 16 MG Daily Dose - 4 MG (28) [PSN] · Lytgobi 16 MG Daily Dose - 4 MG (28) [SY]38These highlights do not include all the information needed to use LYTGOBI safely and effectively. See full prescribing information for LYTGOBI. LYTGOBI ® (futibatinib) tablets, for oral use Initial U.S. Approval: 202220251027